NCT Number: NCT03171467
Salpingectomy at the Time of Elective Laparoscopic Cholecystectomy (SaLCHE)
Prophylactic salpingectomy (also called opportunistic, risk-reducing or incidental salpingectomy) has been advocated at the time of gynecologic surgery to reduce the risk of serous ovarian cancer. This study explores the acceptability and feasibility of opportunistic salpingectomy at the time of elective laparoscopic cholecystectomy (LCHE).
Looking for future studies?
Notify MeKey information
Age range
45 year–75 year
Sex eligibility
Female
Study type
Interventional
Phase
Not applicable
Primary location
Landeskrankenhaus Feldbach, Feldbach, Austria
About this study
Many serous ovarian cancers are now thought to originate in the fimbria of the fallopian tubes. This has led a number of professional societies worldwide to recommend consideration of prophylactic salpingectomy at the time of elective gynecologic surgery or tubal sterilization.
This study explores the acceptability and feasibility of incidental (opportunistic, risk-reducing, prophylactic) salpingectomy at the time of a common nongynecologic procedure in women, i.e. elective laparoscopic cholecystectomy (LCHE). The study addresses whether women ≥45 years would accept opportunistic salpingectomy and the technical feasibility (time, port placement, complications) in women who consented to salpingectomy.
Who can participate
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
- Scheduled (elective) laparoscopic cholecystectomy for a benign indication
- Age >45 years
- Consent
Exclusion criteria
- Age <45 years
- Desire to preserve fertility
- Cholecystectomy for malignant disease
- Extensive previous abdominal surgery
Treatment and study plan
Primary outcomes
-
Feasibility of opportunistic bilateral salpingectomy at the time of laparoscopic cholecystectomy
Time frame: At time of laparoscopic cholecystectomy surgery
Evaluation of how often opportunistic bilateral salpingectomy can be accomplished at the time of laparoscopic cholecystectomy
Secondary outcomes
-
Time
Time frame: At the time of surgery
Time (in minutes) from completion of cholecystectomy to completion of bilateral salpingectomy
-
Port repositioning
Time frame: At surgery
Rate of port repositioning
-
Complications
Time frame: 30 days
Number of complications due to salpingectomy
-
Patient-recorded outcome
Time frame: Preop. and 1 year
Bliem Questionnaire
Sponsors and collaborators
Lead sponsor
Medical University of Graz
Other
Collaborators
- Krankenhaus der Barmherzigen Brüder Graz
- Krankenhaus der Barmherzigen Brüder St. Veit/Glan
- Krankenhaus der Elisabethinen Graz
- LKH Hartberg
- Landeskrankenhaus Feldbach
Registry information
Official study title
Salpingectomy in Women Undergoing Elective Laparoscopic Cholecystectomy (SaLCHE): A Feasibility Study
Acronym: SaLCHE
Important dates
- Study start
- 2016
- Primary completion
- 2018
- Study completion
- 2018
- First posted
- May 31, 2017
- Registry last updated
- Apr 17, 2018
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Related clinical trials
Published trials that share one or more normalized conditions with this study.
Esketamine Combined With Magnesium Sulfate for Postoperative Fatigue Syndrome in Patients Undergoing Laparoscopic Cholecystectomy
NCT07131033
Alleviate Postoperative Fatigue Syndrome, Laparoscopic Cholecystectomy
Huaian, China
View Trial DetailsERAS (Enhanced Recovery After Surgery) and Multimodal Analgesia in Laparoscopic Cholecystectomy
NCT06885086
Agnosia, Laparoscopic Cholecystectomy
Sarıçam, Adana, Turkey (Türkiye)
View Trial DetailsRIPB Versus EOIPB for Pain Control After Laparoscopic Cholecystectomy
NCT07607262
Laparoscopic Cholecystectomy, Neurologic Manifestations
Sancaktepe, Istanbul, Turkey (Türkiye)
View Trial DetailsLow-Flow Sevoflurane and Desflurane Anesthesia in Laparoscopic Cholecystectomy
NCT07440758
Laparoscopic Cholecystectomy, Nausea
Kayseri, Kocasinan, Turkey (Türkiye)
View Trial Details